March 24, 2020 / 8:53 PM / 17 days ago

BRIEF-T2 Biosystems Announces Worldwide Licensing Agreement Of Covid-19 Assay

March 24 (Reuters) - T2 Biosystems Inc:

* T2 BIOSYSTEMS ANNOUNCES WORLDWIDE LICENSING AGREEMENT OF COVID-19, NOVEL CORONAVIRUS ASSAY FROM HACKENSACK MERIDIAN HEALTH’S CENTER FOR DISCOVERY AND INNOVATION

* T2 BIOSYSTEMS INC - WILL ADAPT CORONAVIRUS TEST TO RUN ON ITS T2DX INSTRUMENT

* T2 BIOSYSTEMS INC - HACKENSACK MERIDIAN HEALTH WILL ALSO ADOPT T2DX INSTRUMENT AND TEST PANELS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below